|
Elizabeth Djinis Via the Hearld-Tribune
Read the Complete Article Here The Co-Founder of the QuitDoc Foundation and medical director of Sarasota Memorial Hospital’s Clinical Research Center, Dr. Kirk Voelker, has been part of a game-changing COVID-19 Treatment. As part of 12 other research institutions, SMH is taking part in a trial of new drug to treat those hospitalized with respiratory disease and low blood oxygen. “I’ve realized how frustrating it is and how little control we may have over this inflammatory response, so the fact that we now have a drug trial that addresses the inflammatory response is actually very exciting for me,” he said. “I am very hopeful that this will somehow make a difference.” When asked the goal of the trial, Voelker kept it simple: “To save lives.” Read more about the trial here.
3 Comments
5/26/2025 01:50:45 pm
Thanks for this wonderful post. The information in this article is very helpful to me. Thanks a lot for sharing. Keep blogging. 5/26/2025 01:51:09 pm
Usually I never comment on blogs but your article is so convincing that, I never stop myself to say something about it. You’re doing a great job Man,Keep it up. 5/31/2025 10:33:20 am
It's encouraging to see Sarasota Memorial Hospital launching a clinical trial for COVID-19 treatment. Advancing research is crucial to finding effective therapies and saving lives. Best wishes! Leave a Reply. |
RSS Feed
